Literature DB >> 26101696

Homeostasis of redox status derived from glucose metabolic pathway could be the key to understanding the Warburg effect.

Shiwu Zhang1, Chuanwei Yang2, Zhenduo Yang1, Dan Zhang1, Xiaoping Ma3, Gordon Mills4, Zesheng Liu4.   

Abstract

Glucose metabolism in mitochondria through oxidative phosphorylation (OXPHOS) for generation of adenosine triphosphate (ATP) is vital for cell function. However, reactive oxygen species (ROS), a by-product from OXPHOS, is a major source of endogenously produced toxic stressors on the genome. In fact, ATP could be efficiently produced in a high throughput manner without ROS generation in cytosol through glycolysis, which could be a unique and critical metabolic pathway to prevent spontaneous mutation during DNA replication. Therefore glycolysis is dominant in robust proliferating cells. Indeed, aerobic glycolysis, or the Warburg effect, in normal proliferating cells is an example of homeostasis of redox status by transiently shifting metabolic flux from OXPHOS to glycolysis to avoid ROS generation during DNA synthesis and protect genome integrity. The process of maintaining redox homeostasis is driven by genome wide transcriptional clustering with mitochondrial retrograde signaling and coupled with the glucose metabolic pathway and cell division cycle. On the contrary, the Warburg effect in cancer cells is the results of the alteration of redox status from a reprogramed glucose metabolic pathway caused by the dysfunctional OXPHOS. Mutations in mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) disrupt mitochondrial structural integrity, leading to reduced OXPHOS capacity, sustained glycolysis and excessive ROS leak, all of which are responsible for tumor initiation, progression and metastasis. A "plumbing model" is used to illustrate how redox status could be regulated through glucose metabolic pathway and provide a new insight into the understanding of the Warburg effect in both normal and cancer cells.

Entities:  

Keywords:  Mitochondrial bioredox; glucose metabolic pathway; glycolysis; mitochondrial dynamics; the Warburg effect

Year:  2015        PMID: 26101696      PMCID: PMC4473309     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  111 in total

1.  Redox regulation of the mitochondrial K(ATP) channel in cardioprotection.

Authors:  Bruno B Queliconi; Andrew P Wojtovich; Sergiy M Nadtochiy; Alicia J Kowaltowski; Paul S Brookes
Journal:  Biochim Biophys Acta       Date:  2010-11-20

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 3.  Mutant p53 reactivation by small molecules makes its way to the clinic.

Authors:  Vladimir J N Bykov; Klas G Wiman
Journal:  FEBS Lett       Date:  2014-04-24       Impact factor: 4.124

Review 4.  Mitochondrial DNA transmission, replication and inheritance: a journey from the gamete through the embryo and into offspring and embryonic stem cells.

Authors:  Justin C St John; Joao Facucho-Oliveira; Yan Jiang; Richard Kelly; Rana Salah
Journal:  Hum Reprod Update       Date:  2010-03-15       Impact factor: 15.610

5.  Ultrastructural bases for metabolically linked mechanical activity in mitochondria. I. Reversible ultrastructural changes with change in metabolic steady state in isolated liver mitochondria.

Authors:  C R Hackenbrock
Journal:  J Cell Biol       Date:  1966-08       Impact factor: 10.539

Review 6.  The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression.

Authors:  Rodrigo Diaz-Ruiz; Michel Rigoulet; Anne Devin
Journal:  Biochim Biophys Acta       Date:  2010-09-08

Review 7.  Why size matters - balancing mitochondrial dynamics in Alzheimer's disease.

Authors:  Brian DuBoff; Mel Feany; Jürgen Götz
Journal:  Trends Neurosci       Date:  2013-04-11       Impact factor: 13.837

8.  Effect of specific growth rate on fermentative capacity of baker's yeast.

Authors:  P Van Hoek; J P Van Dijken; J T Pronk
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792

Review 9.  Saccharomyces cerevisiae as a model system to study the response to anticancer agents.

Authors:  Renata Matuo; Fabrício G Sousa; Daniele G Soares; Diego Bonatto; Jenifer Saffi; Alexandre E Escargueil; Annette K Larsen; João Antonio Pêgas Henriques
Journal:  Cancer Chemother Pharmacol       Date:  2012-08-01       Impact factor: 3.333

10.  Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome.

Authors:  Vincent Vuaroqueaux; Patrick Urban; Martin Labuhn; Mauro Delorenzi; Pratyaksha Wirapati; Christopher C Benz; Renata Flury; Holger Dieterich; Frédérique Spyratos; Urs Eppenberger; Serenella Eppenberger-Castori
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more
  9 in total

1.  In vivo assessment of intracellular redox state in rat liver using hyperpolarized [1-13 C]Alanine.

Authors:  Jae Mo Park; Chalermchai Khemtong; Shie-Chau Liu; Ralph E Hurd; Daniel M Spielman
Journal:  Magn Reson Med       Date:  2017-03-05       Impact factor: 4.668

2.  A defined metabolic state in pre B cells governs B-cell development and is counterbalanced by Swiprosin-2/EFhd1.

Authors:  Merle Stein; Sebastian Dütting; Dimitrios Mougiakakos; Michael Bösl; Kristin Fritsch; Dorothea Reimer; Sophia Urbanczyk; Tobit Steinmetz; Wolfgang Schuh; Aline Bozec; Thomas H Winkler; Hans-Martin Jäck; Dirk Mielenz
Journal:  Cell Death Differ       Date:  2017-05-19       Impact factor: 15.828

Review 3.  Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products.

Authors:  Giuseppina Barrera; Fabrizio Gentile; Stefania Pizzimenti; Rosa Angela Canuto; Martina Daga; Alessia Arcaro; Giovanni Paolo Cetrangolo; Alessio Lepore; Carlo Ferretti; Chiara Dianzani; Giuliana Muzio
Journal:  Antioxidants (Basel)       Date:  2016-02-19

4.  The Enzymology of 2-Hydroxyglutarate, 2-Hydroxyglutaramate and 2-Hydroxysuccinamate and Their Relationship to Oncometabolites.

Authors:  Vivek A Hariharan; Travis T Denton; Sarah Paraszcszak; Kyle McEvoy; Thomas M Jeitner; Boris F Krasnikov; Arthur J L Cooper
Journal:  Biology (Basel)       Date:  2017-03-30

Review 5.  Exon 3 mutations of CTNNB1 drive tumorigenesis: a review.

Authors:  Chao Gao; Yingmei Wang; Russell Broaddus; Longhao Sun; Fengxia Xue; Wei Zhang
Journal:  Oncotarget       Date:  2017-11-24

Review 6.  Regulation of Energy Metabolism during Early B Lymphocyte Development.

Authors:  Sophia Urbanczyk; Merle Stein; Wolfgang Schuh; Hans-Martin Jäck; Dimitrios Mougiakakos; Dirk Mielenz
Journal:  Int J Mol Sci       Date:  2018-07-27       Impact factor: 5.923

7.  DHA and 19,20-EDP induce lysosomal-proteolytic-dependent cytotoxicity through de novo ceramide production in H9c2 cells with a glycolytic profile.

Authors:  Tomoko Endo; Victor Samokhvalov; Ahmed M Darwesh; Kevin M W Khey; Ahmed A El-Sherbeni; Ayman O S Ei-Kadi; Takuji Machida; Masahiko Hirafuji; John M Seubert
Journal:  Cell Death Discov       Date:  2018-08-20

Review 8.  Molecular Aspects of Colorectal Adenomas: The Interplay among Microenvironment, Oxidative Stress, and Predisposition.

Authors:  Gitana Maria Aceto; Teresa Catalano; Maria Cristina Curia
Journal:  Biomed Res Int       Date:  2020-03-16       Impact factor: 3.411

Review 9.  Mitochondria and chronic effects of cancer therapeutics: The clinical implications.

Authors:  Abishai Dominic; Dale Hamilton; Jun-Ichi Abe
Journal:  J Thromb Thrombolysis       Date:  2020-10-20       Impact factor: 2.300

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.